VAXCYTE, INC. Property, Plant and Equipment, Gross
VAXCYTE, INC. (PCVX) had Property, Plant and Equipment, Gross of $290.14 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-24
- 2025-12-31: Property, Plant and Equipment, Gross $290.14M.
- 2024-12-31: Property, Plant and Equipment, Gross $214.32M.
- 2024-09-30: Property, Plant and Equipment, Gross $176.65M.
- 2024-06-30: Property, Plant and Equipment, Gross $137.60M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $290.14M 10-K · filed 2026-02-24 |
| 2024-12-31 | $214.32M 10-K · filed 2026-02-24 |
| 2024-09-30 | $176.65M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $137.60M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $95.11M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $88.90M 10-K · filed 2025-02-25 |
| 2023-09-30 | $19.82M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $24.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $22.03M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $16.48M 10-K · filed 2024-02-27 |
| 2022-09-30 | $15.36M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $14.91M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $14.26M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $11.50M 10-K · filed 2023-02-27 |
| 2021-09-30 | $12.04M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $10.59M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $9.44M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $7.37M 10-K · filed 2022-02-28 |
| 2020-09-30 | $6.37M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $6.25M 10-Q · filed 2020-08-12 |
| 2019-12-31 | $6.37M 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |